| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
35,133 |
32,181 |
$3.59M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
13,177 |
12,001 |
$2.06M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39,992 |
33,869 |
$1.33M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
47,725 |
40,528 |
$1.30M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,339 |
3,805 |
$832K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
15,944 |
14,213 |
$801K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,882 |
2,234 |
$582K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
6,960 |
6,486 |
$506K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12,038 |
10,806 |
$440K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,263 |
1,141 |
$354K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
23,427 |
11,652 |
$309K |
| 71045 |
Radiologic examination, chest; single view |
5,956 |
5,267 |
$295K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
10,389 |
8,976 |
$270K |
| 45384 |
|
1,586 |
1,268 |
$254K |
| 20610 |
|
1,131 |
963 |
$252K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
10,653 |
9,103 |
$220K |
| 80053 |
Comprehensive metabolic panel |
30,355 |
25,406 |
$210K |
| G0378 |
Hospital observation service, per hour |
583 |
383 |
$206K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,630 |
6,882 |
$185K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
5,126 |
3,803 |
$181K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
359 |
315 |
$175K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
559 |
523 |
$166K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
31,691 |
26,358 |
$158K |
| 71046 |
Radiologic examination, chest; 2 views |
1,860 |
1,670 |
$118K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,609 |
5,946 |
$102K |
| 36415 |
Collection of venous blood by venipuncture |
42,476 |
34,305 |
$78K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
446 |
418 |
$77K |
| 92551 |
|
508 |
470 |
$57K |
| 73630 |
|
610 |
546 |
$44K |
| 84484 |
|
6,449 |
5,075 |
$40K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
950 |
842 |
$39K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,218 |
1,515 |
$39K |
| 81025 |
|
5,956 |
5,215 |
$38K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
91 |
76 |
$37K |
| 94060 |
|
315 |
277 |
$35K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,704 |
2,407 |
$35K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
606 |
507 |
$34K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
76 |
65 |
$27K |
| 90834 |
Psychotherapy, 45 minutes with patient |
703 |
573 |
$24K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
745 |
668 |
$23K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
744 |
668 |
$23K |
| 81001 |
|
11,389 |
9,930 |
$23K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
931 |
876 |
$23K |
| 90686 |
|
1,108 |
1,034 |
$22K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
53 |
43 |
$21K |
| 73562 |
|
255 |
242 |
$21K |
| 80061 |
Lipid panel |
1,904 |
1,818 |
$21K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,729 |
2,528 |
$21K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
744 |
690 |
$19K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
108 |
101 |
$19K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,063 |
2,732 |
$17K |
| 81003 |
|
7,772 |
5,918 |
$16K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,445 |
3,883 |
$15K |
| 87070 |
|
2,150 |
1,833 |
$13K |
| 31231 |
|
25 |
24 |
$12K |
| 94729 |
|
258 |
241 |
$11K |
| 87807 |
|
1,024 |
876 |
$11K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
53 |
52 |
$11K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
994 |
654 |
$11K |
| 83735 |
|
2,779 |
2,368 |
$10K |
| 87522 |
Neg quan hep c or qual rna |
273 |
243 |
$10K |
| 83690 |
|
2,143 |
1,899 |
$10K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
79 |
73 |
$9K |
| 93017 |
|
132 |
125 |
$9K |
| 90682 |
|
174 |
173 |
$9K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
217 |
204 |
$8K |
| 94727 |
|
189 |
168 |
$8K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
19 |
12 |
$8K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
144 |
122 |
$8K |
| 99215 |
Prolong outpt/office vis |
139 |
130 |
$8K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,366 |
1,194 |
$7K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,997 |
2,596 |
$7K |
| 87040 |
|
756 |
445 |
$6K |
| 83880 |
|
339 |
284 |
$5K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
704 |
639 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
348 |
334 |
$5K |
| 80050 |
General health panel |
113 |
109 |
$5K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
184 |
156 |
$4K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
358 |
321 |
$3K |
| 52000 |
|
13 |
13 |
$3K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
46 |
42 |
$3K |
| G0127 |
Trimming of dystrophic nails, any number |
222 |
214 |
$3K |
| 90832 |
Psychotherapy, 30 minutes with patient |
179 |
142 |
$3K |
| 96376 |
|
96 |
61 |
$3K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
52 |
52 |
$3K |
| 73030 |
|
43 |
36 |
$3K |
| 81002 |
|
1,079 |
730 |
$3K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
15 |
13 |
$3K |
| 97802 |
|
135 |
118 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
723 |
589 |
$3K |
| 93925 |
|
33 |
30 |
$3K |
| 99173 |
|
438 |
371 |
$2K |
| 11719 |
|
120 |
111 |
$2K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
72 |
52 |
$2K |
| 87536 |
|
40 |
37 |
$2K |
| 85610 |
|
933 |
821 |
$2K |
| 73130 |
|
50 |
42 |
$2K |
| 88142 |
|
220 |
200 |
$2K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
34 |
29 |
$2K |
| 85730 |
|
688 |
586 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
12,344 |
9,725 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
54 |
53 |
$2K |
| 80076 |
|
293 |
257 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
12 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
336 |
290 |
$2K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
114 |
92 |
$2K |
| 87081 |
|
259 |
243 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
552 |
468 |
$2K |
| 83605 |
|
255 |
206 |
$2K |
| 94664 |
|
170 |
104 |
$1K |
| 82962 |
|
867 |
556 |
$1K |
| 72170 |
|
25 |
25 |
$1K |
| 86360 |
|
38 |
37 |
$1K |
| 82105 |
|
104 |
97 |
$1K |
| 83655 |
|
140 |
108 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,835 |
3,649 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
54 |
38 |
$1K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
14 |
13 |
$1K |
| 86359 |
|
39 |
37 |
$1K |
| 82077 |
|
163 |
131 |
$1K |
| 96160 |
|
85 |
71 |
$1K |
| 87428 |
|
61 |
53 |
$1K |
| 43450 |
|
1,875 |
1,112 |
$1K |
| 82570 |
|
261 |
241 |
$1K |
| 0001A |
|
494 |
369 |
$1K |
| 82043 |
|
215 |
200 |
$1K |
| 93041 |
|
101 |
78 |
$1K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,514 |
1,913 |
$998.37 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
557 |
421 |
$834.79 |
| 92134 |
|
60 |
54 |
$802.78 |
| G0008 |
Administration of influenza virus vaccine |
2,081 |
1,381 |
$782.28 |
| 84439 |
|
88 |
87 |
$718.68 |
| 85018 |
|
317 |
285 |
$706.11 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
78 |
28 |
$696.75 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
6,999 |
6,181 |
$689.79 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
52 |
43 |
$683.85 |
| 90715 |
|
14 |
12 |
$614.22 |
| 82550 |
|
167 |
139 |
$609.42 |
| 90461 |
|
700 |
434 |
$602.63 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
26 |
24 |
$549.75 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
944 |
630 |
$525.18 |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
18 |
12 |
$481.27 |
| 90670 |
|
247 |
211 |
$418.32 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
14 |
13 |
$397.97 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
15 |
12 |
$394.19 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
13 |
13 |
$389.90 |
| 92083 |
|
13 |
13 |
$372.42 |
| 87186 |
|
75 |
54 |
$328.70 |
| 85379 |
|
49 |
48 |
$315.58 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
127 |
111 |
$312.10 |
| 84550 |
|
76 |
72 |
$311.03 |
| 84100 |
|
149 |
131 |
$306.75 |
| 87340 |
|
26 |
26 |
$298.88 |
| 90673 |
|
399 |
87 |
$284.16 |
| 99201 |
|
12 |
12 |
$258.88 |
| 84481 |
|
26 |
25 |
$237.09 |
| 92133 |
|
13 |
13 |
$236.32 |
| 87077 |
|
45 |
43 |
$234.32 |
| 93922 |
|
18 |
16 |
$232.78 |
| 85652 |
|
92 |
86 |
$217.44 |
| 82150 |
|
52 |
42 |
$200.88 |
| 86704 |
|
12 |
12 |
$174.72 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
45 |
39 |
$168.53 |
| 92015 |
Determination of refractive state |
29 |
24 |
$153.60 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,748 |
1,449 |
$145.04 |
| 86592 |
|
39 |
37 |
$143.62 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
25 |
24 |
$140.98 |
| 86140 |
|
25 |
25 |
$133.40 |
| 87210 |
|
47 |
40 |
$115.82 |
| 90671 |
|
625 |
377 |
$106.98 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
44 |
27 |
$106.26 |
| 90681 |
|
115 |
42 |
$103.93 |
| 90698 |
|
117 |
89 |
$101.59 |
| 36416 |
|
107 |
79 |
$90.10 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
81 |
69 |
$88.21 |
| 86850 |
|
17 |
15 |
$80.88 |
| 86431 |
|
12 |
12 |
$68.75 |
| J2704 |
Injection, propofol, 10 mg |
6,239 |
2,793 |
$47.08 |
| 86900 |
|
17 |
15 |
$35.88 |
| 86901 |
|
17 |
15 |
$35.88 |
| 82270 |
|
12 |
12 |
$33.72 |
| S0028 |
Injection, famotidine, 20 mg |
14 |
14 |
$28.60 |
| 90633 |
|
187 |
123 |
$22.77 |
| G0009 |
Administration of pneumococcal vaccine |
44 |
24 |
$21.09 |
| 90474 |
|
23 |
12 |
$5.02 |
| 88312 |
|
247 |
231 |
$0.00 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
290 |
234 |
$0.00 |
| 90685 |
|
56 |
45 |
$0.00 |
| 0002A |
|
60 |
55 |
$0.00 |
| 80320 |
|
36 |
29 |
$0.00 |
| 88342 |
|
713 |
592 |
$0.00 |
| A9270 |
Non-covered item or service |
392 |
316 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,205 |
1,788 |
$0.00 |
| 90677 |
|
26 |
19 |
$0.00 |
| 90680 |
|
132 |
85 |
$0.00 |
| 90697 |
|
138 |
96 |
$0.00 |
| 90656 |
|
128 |
87 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
13 |
13 |
$0.00 |